The prognostic role of sporadic TP53 mutations in the triple-negative breast cancer group

被引：0
|
作者：
Maksimenko, E. [1 ]
Irmejs, A. [1 ]
Berzina, D. [1 ]
Nakazawa-Miklasevica, M. [2 ]
Trofimovics, G. [3 ]
Gardovkis, J. [3 ]
Miklasevics, E. [1 ]
机构：
[1] Riga Stradins Univ, Inst Oncol, Riga, Latvia
[2] Riga Stradins Univ, Inst Oncol, Mol Genet Lab, Riga, Latvia
[3] Riga Stradins Univ, Riga, Latvia
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [21] Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
    Li, Xuerui
    Chen, Xiaoqing
    Wen, Lingzhu
    Wang, Yulei
    Chen, Bo
    Xue, Yunlian
    Guo, Liping
    Liao, Ning
    THORACIC CANCER, 2020, 11 (07) : 1861 - 1868
  • [22] TP53 Mutations in Breast and Ovarian Cancer
    Silwal-Pandit, Laxmi
    Langerod, Anita
    Borresen-Dale, Anne-Lise
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (01):
  • [23] Prognostic value of BRCA mutations in triple-negative breast cancer
    Guerrero-Setas, D.
    Freire, J.
    Garcia-Berbel, P.
    Ruiz De Azua, Y.
    De la Cruz, S.
    Armendariz, P.
    Mercado, M. D. R.
    Aguiar, B.
    Arriola, M.
    Gomez-Roman, J.
    Cordoba, A.
    VIRCHOWS ARCHIV, 2020, 477 : S143 - S144
  • [24] Targeted therapies for triple negative breast cancer based on TP53 status
    Ma, C. X.
    Li, S.
    Guo, Z.
    Chris, R. E.
    Hoog, J.
    Lin, L.
    Ellis, M. J.
    Piwnica-Worms, H. M.
    CANCER RESEARCH, 2009, 69 (02) : 92S - 92S
  • [25] TP53 and Histone H3.3 Mutations in Triple-Negative Lower-Grade Gliomas
    Chan, Aden K.
    Mao, Ying
    Ng, Ho-Keung
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22): : 2206 - 2208
  • [26] Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer; [Assoziation von TP53-Mutationen mit TP53-Codon-72-Polymorphismus und Verlauf bei dreifach negativem Mammakarzinom]
    Foedermayr M.
    Sebesta M.
    Rudas M.
    Berghoff A.S.
    Promberger R.
    Preusser M.
    Dubsky P.
    Gnant M.
    Steger G.G.
    Weltermann A.
    Zielinski C.C.
    Zach O.
    Bartsch R.
    memo - Magazine of European Medical Oncology, 2016, 9 (2) : 70 - 75
  • [27] Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
    A Langerød
    TI Andersen
    I Bukholm
    A-L Børresen Dale
    Breast Cancer Research, 2 (Suppl 1)
  • [28] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [29] TP53 mutation is a biomarker for prognosis in triple-negative breast cancer patients treated with post-neoadjuvant cisplatin
    Hancock, B. A.
    Chen, Y-H
    Solzak, J. P.
    Miller, K. D.
    Radovich, M.
    CANCER RESEARCH, 2016, 76
  • [30] TP53 mutation is a biomarker for prognosis in triple-negative breast cancer patients treated with post-neoadjuvant cisplatin
    Hancock, Bradley
    Chen, Yu-Hsiang
    Solzak, Jeffrey
    Miller, Kathy
    Radovich, Milan
    CANCER RESEARCH, 2016, 76
12345